Amneal Pharmaceuticals, Inc. (AMRX)
13.20
-0.52
(-3.79%)
USD |
NASDAQ |
May 08, 16:00
13.20
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals EPS Diluted (Quarterly) : 0.1893 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | 0.1501 |
| Pfizer Inc. | 0.4688 |
| Crinetics Pharmaceuticals, Inc. | -1.228 |
| Prestige Consumer Healthcare, Inc. | 0.9711 |
| Amphastar Pharmaceuticals, Inc. | 0.1382 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 78.00M |
| Revenue (Quarterly) | 722.52M |
| Total Expenses (Quarterly) | 660.26M |
| Enterprise Value | 6.791B |
| Gross Profit Margin (Quarterly) | 44.31% |
| Profit Margin (Quarterly) | 10.80% |
| Earnings Yield | 2.83% |
| Operating Earnings Yield | 10.32% |
| Normalized Earnings Yield | 3.65 |